JAG
Journey Advisory Group Portfolio holdings
AUM
$1.28B
This Quarter Return
+4.24%
1 Year Return
+12.51%
3 Year Return
+54.51%
5 Year Return
–
10 Year Return
–
AUM
$286M
AUM Growth
+$286M
(+7%)
Cap. Flow
+$9.26M
Cap. Flow
% of AUM
3.24%
Top 10 Holdings %
Top 10 Hldgs %
33.12%
Holding
195
New
15
Increased
80
Reduced
61
Closed
1
Top Buys
| 1 |
Blackrock
BLK
|
$1.52M |
| 2 |
Microsoft
MSFT
|
$1.01M |
| 3 |
Vanguard Total Bond Market
BND
|
$980K |
| 4 |
JPMorgan Ultra-Short Income ETF
JPST
|
$570K |
| 5 |
Invesco QQQ Trust
QQQ
|
$561K |
Top Sells
| 1 |
US Bancorp
USB
|
$1.98M |
| 2 |
iShares Silver Trust
SLV
|
$846K |
| 3 |
AT&T
T
|
$454K |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
$341K |
| 5 |
ProShares Long Online/Short Stores ETF
CLIX
|
$216K |
Sector Composition
| 1 | Technology | 15.33% |
| 2 | Healthcare | 9.83% |
| 3 | Consumer Staples | 8.8% |
| 4 | Financials | 7.67% |
| 5 | Industrials | 6.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
PepsiCo
PEP
$204B
| $2.93M | 1.02% |
20,708
+714
| +4% | +$101K |
|
27
Schwab Intermediately-Term US Treasury ETF
SCHR
$11.5B
| $2.81M | 0.98% |
49,732
-1,457
| -3% | -$82.2K |
|
|
28
Blackrock
BLK
$175B
| $2.66M | 0.93% |
3,529
+2,013
| +133% | +$1.52M |
|
29
Humana
HUM
$36.5B
| $2.62M | 0.92% |
6,250
+100
| +2% | +$41.9K |
|
|
30
iShares Silver Trust
SLV
$19.6B
| $2.59M | 0.91% |
114,260
-37,250
| -25% | -$846K |
|
31
Edwards Lifesciences
EW
$47.8B
| $2.45M | 0.86% |
29,339
-190
| -0.6% | -$15.9K |
|
32
iShares Biotechnology ETF
IBB
$5.6B
| $2.31M | 0.81% |
15,339
+444
| +3% | +$66.8K |
|
33
FedEx
FDX
$54.5B
| $2.24M | 0.78% |
7,897
+200
| +3% | +$56.8K |
|
34
Chubb
CB
$110B
| $2.22M | 0.78% |
14,063
-31
| -0.2% | -$4.9K |
|
35
Invesco Preferred ETF
PGX
$3.85B
| $2.2M | 0.77% |
146,372
+1,289
| +0.9% | +$19.3K |
|
36
Duke Energy
DUK
$95.3B
| $2.19M | 0.77% |
22,702
-341
| -1% | -$32.9K |
|
37
Verizon
VZ
$186B
| $2.03M | 0.71% |
34,978
-63
| -0.2% | -$3.66K |
|
38
Exxon Mobil
XOM
$487B
| $1.99M | 0.7% |
35,628
-1,091
| -3% | -$60.9K |
|
39
Pfizer
PFE
$141B
| $1.98M | 0.69% |
54,671
+3
| +0% | +$109 |
|
40
Crown Castle
CCI
$43.2B
| $1.98M | 0.69% |
11,492
+1,161
| +11% | +$200K |
|
41
Merck
MRK
$210B
| $1.97M | 0.69% |
25,568
+5
| +0% | +$385 |
|
42
CSX Corp
CSX
$60.6B
| $1.96M | 0.69% |
20,337
| – | – |
|
43
Berkshire Hathaway Class A
BRK.A
$1.09T
| $1.93M | 0.67% |
5
| – | – |
|
44
Intel
INTC
$107B
| $1.9M | 0.66% |
29,700
+1
| +0% | +$64 |
|
45
TJX Companies
TJX
$152B
| $1.78M | 0.62% |
26,921
-1
| -0% | -$66 |
|
46
Northrop Grumman
NOC
$84.5B
| $1.77M | 0.62% |
5,454
| – | – |
|
47
Alphabet (Google) Class A
GOOGL
$2.57T
| $1.74M | 0.61% |
841
+27
| +3% | +$55.7K |
|
48
Clorox
CLX
$14.5B
| $1.69M | 0.59% |
8,758
+209
| +2% | +$40.3K |
|
49
3M
MMM
$82.8B
| $1.69M | 0.59% |
8,751
-114
| -1% | -$22K |
|
50
AbbVie
ABBV
$372B
| $1.67M | 0.59% |
15,461
+536
| +4% | +$58K |
|